We’re finding answers.

Dr Mohit Misra brings 20 years of broad healthcare experience to Mango Sciences with a background as a surgeon, trained health economist, top tier strategy consultant, and investor with experience building teams in early stage companies.

Until recently, Mohit was Head of Digital Health at TPG’s Evercare Health Fund. Prior to this, he was Chief Medical Officer and VP of Health Systems of the Harvard big data spin out Aetion, leading a commercial team in working across Europe and the US. He has also worked extensively in life sciences strategy consulting in Europe and the US at London-based Booz&Co. Mohit has policy experience at the UK Dept. of Health and the World Health Organization, and sat on the prestigious UK NICE Health Technology Assessment Committee who assess all new drugs for the NHS for 6 years.

He obtained his Bachelors in Immunology and MD from King’s College London and his Masters in Health Economics from the London School of Economics.

Vamsi Chandra Kasivajjala brings over 20 years of health tech experience to Mango Sciences as a serial entrepreneur with three successful exits.

He co-founded Enlightiks and grew it to be the world’s 8th largest Provider AI & Analytics platform with over 28 million patient lives. Previously, he served as an advisor to Govt of Karnatakam and Head of Operations for Philips Informatics Division in India. Vamsi created Asia’s third largest health tech product division at SRIT and built and implemented EMR, medical imaging, CDSS products, and more at hundreds of hospitals across 40 countries, finally successfully sold the division to Religare Technologies (Healthfore) and continuing to lead as CTO. Prior to that, Vamsi implemented tele-medicine technologies in 11 countries in Eastern and Sub Saharan Africa and before that he built India’s largest Beowulf Cluster Computer.

Vamsi studied Computer Science at IIT Kharagpur and is currently on the Board of Foundation AI and HIMSS India chapter. He was also mentioned by the current Microsoft CEO Satya Nadella in his book ‘Hit Refresh’ for his Atrial Fibrillation model and has published 8 papers in Healthcare AI.

Gavin comes with a proven track record and he is an accomplished leader responsible for developing and managing the RWE Analytics franchise, supporting all analytic functions serving the life science industry. Gavin has worked extensively in outcomes research, partnering with clients to develop research ideas that crystalize the value story of their products. Gavin has got 15+ years of data science experience in Life Sciences & customer-facing engagements, leading the team from data selection and study design through to communication of final recommendations.

Gavin’s current interest & focus area is innovation in the application of AI/machine learning to real-world data. Gavin has completed his Masters from Harvard T H Chan School of Public Health, Boston, MA, and Bachelors from Massachusetts Institute of Technology (MIT), Cambridge, MA.

Sara is Mango Sciences’ Advisor, bringing more than fifteen years of experience working at the intersection of healthcare data, advanced analytics, R&D/drug development, and patient care with all key stakeholders in healthcare – patients, providers, payers and pharmaceutical companies.

Sara started her career working on phase II and III clinical trials in oncology at Dana-Farber Cancer Institute at Harvard before moving on to phase I trials in early clinical development at Novartis. She switched to health economic and outcomes research when she joined Analysis Group in 2008. While at Analysis Group, Sara worked on a variety of projects such as pharmacoeconomics evaluations and outcome studies, study design and data analysis to support medical product marketing, reimbursement strategies, health care policy and regulation, large database retrospective analysis, clinical trial analyses, and meta-analyses. Sara joined the Flatiron Health team to build the quantitative science team, and support the development of pipeline products. Prior to joining Mango Sciences, Sara worked at Aetion, where she led the Science team responsible for research and client delivery. Her research on targeted medication prioritization among risk-stratified patients with diabetes using real world data, won awards at ISPOR and AMCP.

Sara holds a doctorate degree in Statistics from University of Rochester. In her spare time, she enjoys exploring New England with her dog. She also loves to cook and believes in connecting with people through food.

Todd Gorsuch is the Chief Commercial Officer for Mango Sciences. He has two decades of experience driving growth and profitability for early stage companies.

Prior to Mango, he was VP, Head of Commercialization for Harvard big data spin out Aetion where he initially led the Life Sciences global commercial team and then expanded his responsibilities to include global commercialization across the Life Sciences, Health Plan and Provider markets. He was a member of the senior leadership team responsible for raising over $70 million in funding over two rounds. Todd’s experience in the real world evidence market began at Premier, Inc. where he served as the senior sales leader responsible for launching Premier’s life sciences business. His work experience also includes pharmaceutical sales and marketing roles at Merck & Co.

Todd started his career as an officer in the United States Air Force. He obtained his Bachelors of Science degree from the United States Air Force Academy and his MBA from The Citadel’s College of Graduate Studies. When Todd is not working, he can be found unplugged and outdoors enjoying Maine’s four unique and beautiful seasons.